Pharmacotherapy for Body Dysmorphic Disorder.
作者信息
Phillips Katharine A
机构信息
Rhode Island Hospital and the Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI.
出版信息
Psychiatr Ann. 2010 Jul;40(7):325-332. doi: 10.3928/00485713-20100701-05.
Abstract
摘要
相似文献
1
Pharmacotherapy for Body Dysmorphic Disorder.
Psychiatr Ann. 2010 Jul;40(7):325-332. doi: 10.3928/00485713-20100701-05.
2
Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial.
Am J Psychiatry. 2016 Sep 1;173(9):887-95. doi: 10.1176/appi.ajp.2016.15091243. Epub 2016 Apr 8.
3
An update on body dysmorphic disorder.
Curr Opin Psychiatry. 2006 Jan;19(1):74-8. doi: 10.1097/01.yco.0000196159.06165.31.
4
Body dysmorphic disorder in patients with anorexia nervosa: prevalence, clinical features, and delusionality of body image.
Int J Eat Disord. 2002 Nov;32(3):291-300. doi: 10.1002/eat.10091.
5
Body dysmorphic disorder: suggestions for detection and treatment in a surgical dermatology practice.
Dermatol Surg. 2004 Nov;30(11):1391-9. doi: 10.1111/j.1524-4725.2004.30433.x.
6
Prevalence and correlates of body dysmorphic disorder in a community sample of adolescents.
Aust N Z J Psychiatry. 2017 Jun;51(6):595-603. doi: 10.1177/0004867416665483. Epub 2016 Aug 31.
7
Prevalence of body dysmorphic disorder in a community sample of women.
Am J Psychiatry. 2001 Dec;158(12):2061-3. doi: 10.1176/appi.ajp.158.12.2061.
8
Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder.
Am J Psychiatry. 1995 Aug;152(8):1207-9. doi: 10.1176/ajp.152.8.1207.
9
Possible association of body dysmorphic disorder with an occupation or education in art and design.
Am J Psychiatry. 2002 Oct;159(10):1788-90. doi: 10.1176/appi.ajp.159.10.1788.
10
Body Dysmorphic Symptoms, Functional Impairment, and Depression: The Role of Appearance-Based Teasing.
J Psychol. 2016;150(1):119-31. doi: 10.1080/00223980.2015.1012144. Epub 2015 Feb 23.
引用本文的文献
1
Body Dysmorphic Disorder: 21st Century Challenges.
Int J Dermatol. 2025 Aug;64(8):1342-1348. doi: 10.1111/ijd.17708. Epub 2025 Feb 28.
2
Advancing Psychosocial Treatment for Body Dysmorphic Disorder: A State-of-the-Science Review.
Behav Ther. 2024 Nov;55(6):1249-1288. doi: 10.1016/j.beth.2024.04.002. Epub 2024 Apr 10.
3
At the Crossroads between Eating Disorders and Body Dysmorphic Disorders-The Case of Bigorexia Nervosa.
Brain Sci. 2023 Aug 24;13(9):1234. doi: 10.3390/brainsci13091234.
4
An integrative model as a step toward increasing the awareness of eating disorders in the general population.
Front Psychiatry. 2023 May 3;14:1184932. doi: 10.3389/fpsyt.2023.1184932. eCollection 2023.
5
Cosmetic Presentations and Challenges of Body Dysmorphic Disorder and Its Collaborative Management.
J Cutan Aesthet Surg. 2021 Jan-Mar;14(1):20-25. doi: 10.4103/JCAS.JCAS_180_20.
6
Pharmacological Treatment of Body Dysmorphic Disorder.
Curr Neuropharmacol. 2019;17(8):697-702. doi: 10.2174/1570159X16666180426153940.
7
New perspectives in the treatment of body dysmorphic disorder.
F1000Res. 2018 Mar 23;7:361. doi: 10.12688/f1000research.13700.1. eCollection 2018.
8
Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directions.
Child Adolesc Psychiatr Clin N Am. 2011 Apr;20(2):287-304. doi: 10.1016/j.chc.2011.01.004.
本文引用的文献
1
A prospective pilot study of levetiracetam for body dysmorphic disorder.
CNS Spectr. 2009 May;14(5):252-60. doi: 10.1017/s1092852900025414.
2
Pharmacotherapy and psychotherapy for body dysmorphic disorder.
Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD005332. doi: 10.1002/14651858.CD005332.pub2.
3
Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder.
Int Clin Psychopharmacol. 2009 Jan;24(1):26-8. doi: 10.1097/YIC.0b013e32831db2e9.
4
Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.
Body Image. 2008 Mar;5(1):13-27. doi: 10.1016/j.bodyim.2007.12.003. Epub 2008 Mar 5.
5
An open-label trial of venlafaxine in body dysmorphic disorder.
CNS Spectr. 2008 Feb;13(2):138-44. doi: 10.1017/s1092852900016291.
6
Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.
Ann Clin Psychiatry. 2006 Oct-Dec;18(4):251-7. doi: 10.1080/10401230600948464.
7
Suicidality in body dysmorphic disorder: a prospective study.
Am J Psychiatry. 2006 Jul;163(7):1280-2. doi: 10.1176/ajp.2006.163.7.1280.
8
An open-label study of escitalopram in body dysmorphic disorder.
Int Clin Psychopharmacol. 2006 May;21(3):177-9. doi: 10.1097/01.yic.0000194378.65460.ef.
9
Suicidal ideation and suicide attempts in body dysmorphic disorder.
J Clin Psychiatry. 2005 Jun;66(6):717-25. doi: 10.4088/jcp.v66n0607.
10
Olanzapine augmentation of fluoxetine in body dysmorphic disorder.
Am J Psychiatry. 2005 May;162(5):1022-3. doi: 10.1176/appi.ajp.162.5.1022-a.
Zotero 插件